Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity Guadalupe Bermudo, Guillermo Suarez-Cuartin, Pilar Rivera-Ortega, Jose Antonio Rodriguez-Portal, Jaume Sauleda, Belen Nuñez, Diego Castillo, Myriam Aburto, Karina Portillo, Eva Balcells, Diana Badenes-Bonet, Claudia Valenzuela, Estrella Fernandez-Fabrellas, Teresa González-Budiño, Esteban Cano, Orlando Acosta, Virginia Leiro-Fernández, Ana Romero, Lurdes Planas-Cerezales, Ana Villar, Amalia Moreno, Rosalia Laporta, Vanesa Vicens-Zygmunt, Jessica Shull, Tomàs Franquet, Patricio Luburich, Maria Molina-Molina

Latin American Registry of Idiopathic Pulmonary Fibrosis (REFIPI): Clinical Characteristics, Evolution and Treatment Fabián Caro, Ivette Buendía-Roldán, Lorena Noriega-Aguirre, María L. Alberti, Alexandre Amaral, Guillermo Arbo, Santiago Auteri, Aníbal Bermúdez, Pablo Curbelo, Manuel de Jesús Díaz Verduzco, Isabel De la Fuente, Juan I. Enghelmayer, Martin Fernández, Matías Florenzano, Fernando Guillen, Ronaldo Kairalla, Yuri Liberato, Carlos Matiz, Mayra Mejía, Viviana Moyano, Alfredo Pachas, Silvia V. Escotorin, Gabriela Tabaj, Esther Tavera, Alvaro Undurraga, Brenda Varela, José Luis Velazquez, Moises Selman

Nintedanib Combined With Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis: A Long-Term Retrospective Multicentre Study (Combi-PF) Corentin Meersseman, Elisa Martínez Besteiro, Nicolas Romain-Scelle, Bruno Crestani, Sylvain Marchand-Adam, Hilario Nunes, Lidwine Wémeau-Stervinou, Raphael Borie, Rémi Diesler, Claudia Valenzuela, Vincent Cottin